about
Healthy living interventions and schizophrenia: a systematic review.Disparities in appendicitis rupture rate among mentally ill patients.European network for promoting the physical health of residents in psychiatric and social care facilities (HELPS): background, aims and methodsGeneration of superoxide anion radicals and platelet glutathione peroxidase activity in patients with schizophrenia.Provision of peer specialist services in VA patient aligned care teams: protocol for testing a cluster randomized implementation trial.Care provided by general practitioners to patients with psychotic disorders: a cohort studyThe contribution of abdominal obesity and dyslipidemia to metabolic syndrome in psychiatric patients.Co-morbidity of smoking in patients with psychiatric and substance use disorders.Antecedents and patterns of suicide behavior in first-admission psychosisAssessment of mortality and marital status of schizophrenic patients over a period of 13 years.Five-year mortality in a cohort of people with schizophrenia in Ethiopia.Community care of patients with schizophrenia: the role of the primary health care teamThe Clarke Institute experience with completed suicide: 1966 to 1997.Incident somatic comorbidity after psychosis: results from a retrospective cohort study based on Flemish general practice data.Item-of-service payments for general practitioner care of severely mentally ill persons: does the money matter?Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Body mass index and quality of life among outpatients with schizophrenia in JapanSuicidality in schizophrenia: a review of the evidence for risk factors and treatment options.Cigarette smoking and mortality risk in people with schizophrenia.Mental health.Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006Schizophrenia in late life: emerging issuesBody composition in patients with schizophrenia: Comparison with healthy controls.Medical co-morbidity risk factors and barriers to care for people with schizophrenia.Atypical antipsychotics in the treatment of depressive and psychotic symptoms in patients with chronic schizophrenia: a naturalistic studyAttitudes toward metabolic adverse events among patients with schizophrenia in Japan.Schizophrenia and suicide: a 10-year review of Kentucky medical examiner cases.Association of metabolic syndrome with schizophreniaA meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controlsFactors associated with substance use problem among Maryland Medicaid enrollees affected by serious mental illness.Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan.Schizophrenia in a Primary Care Setting.Platelet haemostatic function in psychiatric disorders: Effects of antidepressants and antipsychotic drugs.Patterns of care among people with long-term functional psychosis in three different areas of Stockholm County.The effect of nicotine dependence on psychopathology in patients with schizophrenia.The primary care of patients with schizophrenia: a search for good practice.The report of the clinical standard advisory group: standards of care for people with schizophrenia in the UK and implications for mental health nursing.People with long-term mental illness: making shared care work.Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics
P2860
Q31150315-C3BB0F8D-AFBD-452B-9385-066DFAA1957BQ33305689-70CD14A3-09C0-4206-9DC1-1A64E24ADDAFQ33498111-120E3CEA-537F-49A8-990F-47029DFD15D3Q33589462-5779D191-FDA0-453E-B126-19CA9CEEEDA5Q33630420-2136FA4E-B269-4C2E-A053-BECF8630D02DQ33756112-36519724-FE2F-46EB-B202-B782A7892E2EQ33893935-06AA1200-2FC6-4DA4-AFB8-9D730EE921C0Q33942653-967C2296-3D6F-41E3-9B33-815AA866DBFBQ33950963-23FD268D-98F5-41E2-B48A-BFE246B2385AQ34034344-D1C80745-5872-4124-8B1F-3482D93716BBQ34045160-B61EE448-346C-47B0-9D1F-286FA04C40EEQ34054749-9426EF0F-8F8A-4BEF-818C-168FB2747A12Q34073007-25E24106-3FBA-4C0C-BF68-AE1D7FC79900Q34086096-F4F80B55-3B2C-4B68-8C6F-040A50E7D9EBQ34215335-13D511FB-E54C-4EC4-AE35-4D7FDFA406C8Q34623350-00D2C38E-F598-4A91-987A-A4D54E761363Q34660592-0F401767-F819-4B4E-9712-ED39ED291113Q34749204-329085EB-8965-429D-B526-B1735D145C71Q35065406-5A7DDF3F-B652-4FF0-8991-7AA8207F6D57Q35180457-56B5E4B8-F459-4ECE-95E4-0DA4BA57CD1AQ35211109-29C6E59A-5535-4178-9EEE-2F5F840F4532Q35236677-A5CA5BD8-AFE1-4D39-9D1E-867A32987576Q36388181-3B29715A-4ABF-4A18-8919-A24114ED64A5Q36546664-211D93BC-8FC5-4EF3-8366-5E4B0A74B88CQ36584260-7EEA1CC5-4F8C-488F-9223-F1C5A3AB3FE1Q36631551-8D78CF7E-B6D8-4D59-A372-3EEA113C1012Q36841968-DC3B8C57-0955-40B6-ADAA-38318D653CCDQ37201683-1B8F7B60-3125-4F47-BB59-F2B5F038E546Q37236162-6DF04D32-CE8D-4629-A1FD-0275CCC85D95Q37250544-A13E63EF-7816-40F1-B1EC-52B8C9F12262Q37621945-9E7FF6EF-F61B-4C0D-9639-F2231E6B6A2CQ38581178-9E046607-B6E0-4DF4-A71A-ED8750E8FE2DQ38816985-A6056CA5-570E-4F45-9403-728A1C78F6C4Q39243416-B95B6B10-9618-4F01-A515-1178020968E1Q40548353-D8B1D60A-9DD4-412B-9287-86BA50E25F88Q40590271-D07290BD-B307-4418-ABF0-6407BC768E88Q41025867-A93A8B3B-A141-4872-9A8C-D061B1FB04CEQ42547125-5C2D90D9-07FB-4C22-9AC7-A88D00E13541Q42656319-C6BAC183-9EA5-48EB-B58A-D558557DF400Q42805312-EE921D97-4725-4043-9C46-05B5DDB4B64F
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Schizophrenia: a life-shortening disease.
@en
Schizophrenia: a life-shortening disease.
@nl
type
label
Schizophrenia: a life-shortening disease.
@en
Schizophrenia: a life-shortening disease.
@nl
prefLabel
Schizophrenia: a life-shortening disease.
@en
Schizophrenia: a life-shortening disease.
@nl
P356
P1476
Schizophrenia: a life-shortening disease.
@en
P2093
Allebeck P
P356
10.1093/SCHBUL/15.1.81
P407
P577
1989-01-01T00:00:00Z